|

A Prospective Study of Cardiovascular Risk of Patients Admitted for Acute Exacerbation of COPD

RECRUITINGN/ASponsored by Chinese University of Hong Kong
Actively Recruiting
PhaseN/A
SponsorChinese University of Hong Kong
Started2026-01-15
Est. completion2029-01-16
Eligibility
Age40 Years+
Healthy vol.Accepted

Summary

This is a prospective study to assess the burden of existing or hidden cardiovascular (CV) and renal disease in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in a Hong Kong public hospital setting. By implementing a chronic obstructive pulmonary disease (COPD) discharge care bundle with integrated CV/renal screening, the study aims to quantify undiscovered disease prevalence, evaluate risk factors for future exacerbations, and compare re-admission rates against historical controls, ultimately informing integrated cardiopulmonary management strategies.

Eligibility

Age: 40 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age ≥40 years
* Patients hospitalized due to COPD exacerbation.
* Patients diagnosed with COPD, a confirmed COPD diagnosis with a specific FEV1/FVC ratio (\<0.70)
* Able to provide informed consent

Exclusion Criteria:

* Pregnant subjects
* Inability to give informed consent
* Cancer patient who are on active chemotherapy or on palliative care

Conditions1

COPD

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.